Fermenta Biotech Ltd share price logo

Fermenta Biotech Ltd

NSE: FERMENTA

BSE: 506414

Small Cap

Healthcare Sector

₹311.55

-1.00

(-0.32%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Fermenta Biotech Stock Performance

as on April 20, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹308.00
    ₹316.00
    downward going graph

    1.14%

    Downside

    1.43%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹252.15
    ₹399.00
    downward going graph

    19.07%

    Downside

    28.07%

    Upside

    downward going graph

Fermenta Biotech share price movements today

Previous Close
₹312.55
Open
₹308.15
Volume
8,760.00
Upper Circuit
₹386.20
Lower Circuit
₹257.50
Day's Low - High
₹308.00 - ₹316.00
52 Week Low - High
₹252.15 - ₹399.00

Fermenta Biotech Historical Returns

1 Month Return
-7.76 %
3 Month Return
-4.13 %
1 Year Return
+ 8.45 %
3 Year Return
+ 107.95 %
5 Year Return
-6.01 %

Fermenta Biotech Fundamentals

as on April 20, 2026 at 4:01 pm IST

Market Cap

₹916.92 Cr

Return on Equity (ROE)

19.48

PE Ratio (TTM)

10.47

Return on capital employed (ROCE)

17.61

Industry PE ratio

41.98

Beta (LTM)

0.86

P/B Ratio

2.1

Dividend Yield

0.91

PEG Ratio

0.59

Quarterly Earnings Growth YOY

-68.28

EPS (TTM)

26.19

Sector

Pharmaceuticals

Book Value

124.33

Technical Analysis

Bearish

View Technical Analysis

Fermenta Biotech Stock Valuation

as on April 20, 2026 at 4:01 pm IST

Fermenta Biotech in the last 5 years

  • Overview

  • Trends

Lowest (-55.80x)

October 6, 2022

Today (10.47x)

April 17, 2026

Industry (41.98x)

April 17, 2026

Highest (473.02x)

September 6, 2022

LowHigh

Today’s Price to Earnings Ratio: 10.47x

Fermenta Biotech Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Fermenta Biotech with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Fermenta Biotech Ltd image
Fermenta Biotech Ltd
NA916.92-1.2%0.6476469
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY14,124.38-5.89%0.682641,197
Kobo Biotech Ltd image
Kobo Biotech Ltd
NA6.84-10.59%0.00-6NA
Viyash Scientific Ltd image
Viyash Scientific Ltd
BUY9,056.70-4.31%0.72321,551
Deep Health AI India Ltd image
Deep Health AI India Ltd
NA35.7515.94%0.5111
See all

Fermenta Biotech Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
82.45
56.91
98.97
97.34
78.13
95.03
156.47
139.85
136.26
130.22
137.36
Other Income
2.01
1.9
2.52
5.38
2.82
2.88
2.23
3.89
8.77
5.43
3.12
Total Income
84.46
58.8
101.49
102.72
80.95
97.91
158.7
143.74
145.03
135.66
140.48
Expenses
71.51
78.25
73.85
91.97
77.33
76.25
103.2
102.9
108.03
103.59
114.59
Operating Profit
10.94
-21.34
25.12
5.37
0.8
18.78
53.27
36.95
28.23
26.63
22.77
Operating Profit Margin %
13.27%
-37.5%
25.38%
5.52%
1.02%
19.76%
34.04%
26.42%
20.72%
20.45%
16.58%
Profit Before Interest, Tax and Depreciation
12.94
-19.45
27.64
10.76
3.62
21.66
55.5
40.84
37
32.07
25.89
Interest
4.78
3.69
5.19
3.39
3.43
3.69
4.08
2.99
3.11
2.58
3.03
Depreciation
5.95
5.93
6.38
6.46
6.12
6.15
6.08
5.86
5.81
5.41
5.37
Profit Before Tax
2.21
-29.07
16.07
0.91
-5.93
11.82
45.34
31.99
28.08
24.08
17.49
Tax Paid
-
-
6.08
8.05
-
0.7
7.45
-1.34
6.48
6.06
5.46
Profit After Tax
2.21
-29.07
9.99
-7.14
-5.93
11.12
37.89
33.32
21.6
18.03
12.02
Total Net profit including share of profit / Loss from associate company
2.21
-29.07
9.99
-7.14
-5.93
11.12
37.89
33.32
21.6
18.03
12.02
EPS
0.64
-7.32
3.41
-2.41
-2.01
3.94
12.71
11.79
7.49
6.2
4.36
Actual EPS
0.64
-7.32
3.41
-2.41
-2.01
3.94
12.71
11.79
7.49
6.2
4.36
Adjusted EPS
0.64
-7.32
3.41
-2.41
-2.01
3.94
12.71
11.79
7.49
6.2
4.36
Diluted EPS
0.64
-7.32
3.41
-2.41
-2.01
3.94
12.71
11.79
7.47
6.15
4.34

Fermenta Biotech Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
302.67
404.67
292.95
377.29
398.52
349.94
335.66
469.48
Other Income
8.95
12.37
12.32
8.25
8.14
8.6
11.81
11.82
Total Income
311.62
417.04
305.27
385.54
406.65
358.54
347.47
481.3
Expenses
209.65
253.31
237.76
295.63
337.06
360.81
315.58
359.68
Operating Profit
93.02
151.36
55.19
81.66
61.46
-10.87
20.08
109.8
Operating Profit Margin %
30.73%
37.4%
18.84%
21.64%
15.42%
-3.11%
5.98%
23.39%
Profit Before Interest, Tax and Depreciation
101.97
163.72
67.51
89.91
69.59
-2.28
31.89
121.62
Interest
13.63
23.13
9.09
17.97
17.08
20.78
17.05
14.19
Depreciation
12.36
11.89
15
20.31
25.56
28.25
24.72
24.22
Profit Before Tax
75.98
128.7
43.42
51.63
26.95
-51.31
-9.88
83.21
Tax Paid
21.13
10.81
-16.1
9.1
11.89
1.83
14.14
6.8
Profit After Tax
54.84
117.9
59.52
42.53
15.06
-53.13
-24.01
76.4
Total Net profit including share of profit / Loss from associate company
46.35
117.47
59.52
42.53
15.06
-53.13
-24.01
76.4
EPS
36.75
40.72
20.63
15.77
5.35
-17.7
-5.42
26.35
Actual EPS
36.75
40.72
20.63
15.77
5.35
-17.7
-5.42
26.35
Adjusted EPS
3.06
13.57
20.63
15.77
5.35
-17.7
-5.42
26.35
Diluted EPS
36.75
40.7
20.53
15.69
5.33
-17.7
-5.42
26.35

Fermenta Biotech Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
4.44
1.91
59.26
90.34
34.46
62.6
43.44
116.11
105.35
40.9
Cash Flow from Investing Activities
-13.38
6.53
-101.14
-96.58
-43.66
-40.94
-26.04
-55.35
-15.5
-0.15
Cash Flow from Financing Activities
10.42
-12.11
88.81
12.21
-47.44
-1.14
-21.58
-41.38
-90.86
-50.86
Net Cash Flow
1.48
-3.68
46.93
5.99
-56.65
20.52
-4.17
19.37
-1
-10.12

Fermenta Biotech Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
62.06%
62.06%
62.06%
62.06%
62.06%
62.06%
62.06%
64.09%
64.09%
64.09%
64.09%
FII
0%
0%
0%
0%
0%
0.05%
0.02%
0.02%
0.02%
0.02%
0.02%
Public
36.02%
36.05%
36.05%
36.05%
36.11%
36.42%
36.97%
35%
35%
34.75%
33.99%
Total Outstanding Shares
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
Total Shareholders
16,148
15,721
15,150
15,178
14,589
13,221
12,922
12,930
12,845
13,760
14,139

Mutual Funds that own Fermenta Biotech Stock

Check out the Mutual Funds with significant holdings in Fermenta Biotech.

Funds
Holdings
Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth
Bandhan BSE Healthcare Index Fund Direct Growth
0.02%
118

Fermenta Biotech Corporate Actions

View detailed summary of the earnings and dividend history of Fermenta Biotech.

  • Fermenta Biotech Ltd Earnings Results

    Fermenta Biotech Ltd’s net profit fell -65.65% since last year same period to ₹12.68Cr in the Q3 2025-2026. On a quarterly growth basis, Fermenta Biotech Ltd has generated -29.79% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Fermenta Biotech Ltd Dividends May,2025

    In the quarter ending March 2025, Fermenta Biotech Ltd has declared dividend of ₹2.50 per share on 28 May 2025 - translating a dividend yield of 0.80%.

    Read More about Dividends

Indices Featuring Fermenta Biotech Stock

Check stock indices that include Fermenta Biotech.

BSE Healthcare

₹43,543.22

0.39 (▲168.69%)

Insights on Fermenta Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 135.66 Cr → 140.48 Cr (in ₹), with an average increase of 3.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 28.4% return, outperforming this stock by 20.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 64.09% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Lupin Ltd has given 240.0% return, outperforming this stock by 129.6%

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.02% of holdings in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, FERMENTA stock has moved down by -4.1%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 34.75% to 33.99% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 5 quarters, 36.91 Cr → 12.68 Cr (in ₹), with an average decrease of 22.6% per quarter

About Fermenta Biotech Ltd

DupharInterfran (DIL) was established by a technocrat, D V K Raju in 1951 as International Franchises Pvt Ltd. In the early years, the company manufactured and sold toothpaste, antiseptic lotion and pharmaceutical specialities on a loan licence basis, in collaboration with PhilipsDuphar Amsterdam Solvay Duphar and Crookes Laboratories London (participation up to 25% equity). The company changed its name to Crookes Interfran in 1963 and to DupharInterfran in 1971. In 1976, collaborations with Solvay Duphar for manufacturing Vitamin D3 and Isoxypurine hydrochloride, with 38.86% foreign stake, came up. In 1995, DIL launched a rights issue to increase long-term resources and working capital and sold two popular brands - Crocin and LactoCalamine lotion - to Smithkline Beecham Pharmaceuticals and Nicholas Piramal respectively to concentrate on the core business of ethical drugs. As per the Scheme of Arrangement, the pharma business of the company was also transferred to a new entity called Duphar Pharma India and investments in unutilised premises at Thane for a commercial complex with modern facilities were also made. In 2003, the Company expanded manufacturing capacity for Vitamin D and other products like Phenyramidol in Kullu. In 2010, the company signed a contract with Solvay Pharmaceuticals B V in Netherlands and acquired 990000 equity shares of Rs.10 each from Fermenta Biotech Ltd, making it a subsidiary. In 2012, the company launched Penicillin G Acylase catalyst Fermase PA 850 and successful entries of Annual Contract with Solvay Pharmaceuticals B V, a vasodilator. Since then, the company has launched new and improved products - fish oil derived cholesterol for the aquaculture market, Vitamin D 500 feed grade powder in 2020, Vitamin AD2 for oil fortification, and patented technology for enzymatic synthesis of Molnupiravir in 2021. It also established subsidiaries in Mauritius, Germany, and USA. The company changed its name from DIL Limited to Fermenta Biotech Limited (FBL) in 2019.

Revenue: ₹137.36Cr as on December 2025 (Q3 FY26)
Net Profit: ₹12.02Cr as on December 2025 (Q3 FY26)
Listing date: 20 Apr, 2026
Chairperson Name: Pradeep Manjunath Chandan
OrganisationFermenta Biotech Ltd
IndustryPharmaceuticals
CEOPradeep Manjunath Chandan
E-voting on sharesClick here to vote

FAQs

What is Fermenta Biotech share price today?

Fermenta Biotech share price today stands at ₹311.55 as on . Fermenta Biotech share today touched a day high of ₹316 and a low of ₹308.

What is the 52 week high and 52 week low range for Fermenta Biotech share?

Fermenta Biotech touched a 52 week high of ₹399 and a 52 week low of ₹252.15. Fermenta Biotech share price today i.e. is trending at ₹311.55, which is -21.92% down from its 52 week high and 23.56% up from its 52 week low.

What is Fermenta Biotech's market capitalisation today?

Fermenta Biotech market capitalisation is ₹916.92 Cr as on .

How to buy Fermenta Biotech shares?

To buy Fermenta Biotech shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for FERMENTA or Fermenta Biotech Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Fermenta Biotech shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Fermenta Biotech trading volume today?

Fermenta Biotech trading volume is 8,760.00 as on . This means that 8,760.00 shares of Fermenta Biotech were bought and sold on the stock market during today's trading session.